Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Heart attack recovery gets a digital boost: pharmacists take the lead

NCT ID NCT07443982

Disease control Sponsor: National University Heart Centre, Singapore Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a new care model for people who have had a heart attack. It uses digital tools and specially trained pharmacists to help manage health after leaving the hospital. The goal is to reduce the risk of another heart attack or death. The study involves 1,633 adults in Singapore.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

1,633 people

The number who actually took part.

Started

Jan 2023

Expected to finish

Sep 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

21 to 90 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Male or Female, aged 21 to 90 years (inclusive), at the time of signing the informed consent form * Clinically diagnosed with AMI during index hospitalisation * Own a mobile phone with internet access- intervention arm only Exclusion Criteria: * Patients who are planned for palliative care or life expectancy \<1 year * Foreigners who do not have Singaporean citizenship/ Permanent Resident (PR) status * Patients who are enrolled into Healthier SG affiliated with General Practitioners (GPs) * Allergy or intolerance of Angiotensin-Converting Enzyme Inhibitors (ACE-I) or Angiotensin II Receptor Blockers (ARB)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Acute myocardial infarction (AMI) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

acute myocardial infarction

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Acute myocardial infarction (AMI)

Contacts and locations

Locations

  • Changi General Hospital (CGH)

    Singapore, Singapore

  • Khoo Teck Puat Hospital (KTPH)

    Singapore, Singapore

  • National Heart Centre Singapore (NHCS)

    Singapore, Singapore

  • National University Heart Centre, Singapore (NUHCS)

    Singapore, Singapore

  • Ng Teng Fong General Hospital (NTFGH)

    Singapore, Singapore

  • Tan Tock Seng Hospital (TTSH)

    Singapore, Singapore

More trials for these conditions

Other studies related to the condition(s) this trial covers.